Neue Suche | Kongressdetail
Druckansicht
 
 

Wet AMD and DME Drug Development Summit | Virtual Event | April 13-15, 2021

Evvnt Promotion / evvnt
-
13.04.2021 - 15.04.2021  Online
Time: 08:00 - 15:45
 
Kongressthemen
The Wet AMD and DME Drug Development Summit comes at a critical juncture, as the research community progresses novel drug candidates targeting angiogenesis-driven disease, and a pandemic further exposes the treatment limitations for a global aging population.

The treatment landscape for Wet Age-Related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME) has dramatically changed since the first anti-VEGF therapies were approved for ocular neovascularization.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/722199-2?pid=4832

Speakers: Casey Kopczynski, Chief Scientific Officer, Aerie Pharmaceuticals, Kevin Peters, Chief Scientific and Medical Officer and Senior Vice President, Aerpio Therapeutics and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/722199-0?pid=4832
Frau Stephanie Nketia
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 1499.0 - USD 3097.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichisches Rotes KreuzÄrztekammer für WienÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)European Health Forum Gastein